Janus Henderson Group’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-88,839
| Closed | -$7.5M | – | 2507 |
|
2025
Q1 | $7.5M | Sell |
88,839
-283
| -0.3% | -$23.9K | ﹤0.01% | 769 |
|
2024
Q4 | $8.03M | Sell |
89,122
-8,048
| -8% | -$725K | ﹤0.01% | 777 |
|
2024
Q3 | $9.6M | Sell |
97,170
-78,123
| -45% | -$7.72M | ﹤0.01% | 695 |
|
2024
Q2 | $16.3M | Sell |
175,293
-53,568
| -23% | -$4.97M | 0.01% | 608 |
|
2024
Q1 | $21.7M | Sell |
228,861
-1,284
| -0.6% | -$122K | 0.01% | 547 |
|
2023
Q4 | $20.5M | Sell |
230,145
-31,500
| -12% | -$2.81M | 0.01% | 545 |
|
2023
Q3 | $19.1M | Sell |
261,645
-112,225
| -30% | -$8.19M | 0.01% | 543 |
|
2023
Q2 | $31.1M | Sell |
373,870
-58,510
| -14% | -$4.87M | 0.02% | 490 |
|
2023
Q1 | $33M | Sell |
432,380
-65,828
| -13% | -$5.02M | 0.02% | 471 |
|
2022
Q4 | $41.4M | Sell |
498,208
-499,972
| -50% | -$41.5M | 0.03% | 416 |
|
2022
Q3 | $79.2M | Buy |
+998,180
| New | +$79.2M | 0.03% | 405 |
|
2015
Q4 | – | Sell |
-46,785
| Closed | -$2.91M | – | 848 |
|
2015
Q3 | $2.91M | Buy |
46,785
+12,903
| +38% | +$803K | 0.03% | 417 |
|
2015
Q2 | $2.85M | Sell |
33,882
-7,686
| -18% | -$646K | 0.02% | 444 |
|
2015
Q1 | $3.13M | Buy |
+41,568
| New | +$3.13M | 0.02% | 445 |
|
2013
Q4 | – | Sell |
-84,684
| Closed | -$3.65M | – | 780 |
|
2013
Q3 | $3.65M | Buy |
84,684
+7,662
| +10% | +$330K | 0.04% | 303 |
|
2013
Q2 | $2.79M | Buy |
+77,022
| New | +$2.79M | 0.03% | 328 |
|